Renal denervation—a valid treatment option despite SYMPLICITY HTN-3

被引：0
|
作者：
Roland E. Schmieder
机构：
[1] Clinical Research Unit of Hypertension and Vascular Medicine,Department of Nephrology and Hypertension
[2] University Hospital Erlangen,undefined
来源：
Nature Reviews Cardiology | 2014年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：638 / 638
相关论文
共 50 条
  • [21] Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial
    Kandzari, David E.
    Bhatt, Deepak L.
    Sobotka, Paul A.
    O'Neill, William W.
    Esler, Murray
    Flack, John M.
    Katzen, Barry T.
    Leon, Martin B.
    Massaro, Joseph M.
    Negoita, Manuela
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Straley, Craig
    Townsend, Raymond R.
    Bakris, George
    [J]. CLINICAL CARDIOLOGY, 2012, 35 (09) : 528 - 535
  • [22] Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein, Murray
    de Marchena, Eduardo
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (02) : 140 - 149
  • [23] Changes in nocturnal blood pressure post-renal denervation: comparison of treatment versus control groups in SYMPLICITY HTN-3
    Kario, K.
    Bakris, G.
    Pocock, S.
    Fahy, M.
    Bhatt, D. L.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 664 - 664
  • [24] Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure Results From SYMPLICITY HTN-3
    Bakris, George L.
    Townsend, Raymond R.
    Liu, Minglei
    Cohen, Sidney A.
    D'Agostino, Ralph
    Flack, John M.
    Kandzari, David E.
    Katzen, Barry T.
    Leon, Martin B.
    Mauri, Laura
    Negoita, Manuela
    O'Neill, William W.
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : 1071 - 1078
  • [25] FAILURE OF RENAL DENERVATION IN SYMPLICITY HTN-3 IS A PREDICTABLE RESULT OF ANATOMICALLY INADEQUATE OPERATIVE TECHNIQUE AND NOT THE TRUE LIMITATIONS OF THE TECHNOLOGY
    Pekarskiy, S.
    Baev, A.
    Mordovin, V.
    Sitkova, E.
    Semke, G.
    Ripp, T.
    Falkovskaya, A.
    Krylov, A.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E108 - E108
  • [26] New analysis of the SYMPLICITY HTN-3 trial
    Mason, E.
    Tofield, A.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (09) : 535 - 535
  • [27] SYMPLICITY HTN-3 screen failure patient cohort
    Waksman, R.
    Bakris, G. L.
    Steinvil, A.
    Garcia-Garcia, H. M.
    Debruin, V.
    Jolivette, D.
    Jones, D.
    Bhatt, D. L.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 230 - 230
  • [28] Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial
    Kario, Kazuomi
    Bhatt, Deepak L.
    Kandzari, David E.
    Brar, Sandeep
    Flack, John M.
    Gilbert, Colleen
    Oparil, Suzanne
    Robbins, Mark
    Townsend, Raymond R.
    Bakris, George
    [J]. CIRCULATION JOURNAL, 2016, 80 (06) : 1404 - +
  • [29] Current Brief Comment: SYMPLICITY HTN-3: No Surprise?
    Slany, J.
    [J]. JOURNAL FUR HYPERTONIE, 2014, 18 (01): : 19 - 21
  • [30] Opinion of the German Society of Cardiology on the Symplicity HTN-3 Study in Patients with resistant Arterial Hypertension after Renal Denervation
    Boehm, M.
    Hamm, C. W.
    Kuck, K. -H.
    Ertl, G.
    Mahfoud, F.
    Schunkert, H.
    [J]. KARDIOLOGE, 2014, 8 (03): : 244 - 245
12345